23andMe once again opens up patient data, this time to Pfizer

January 13, 2015 11:05 AM

16 0

For the second time in as many weeks, the DNA-testing startup 23andMe is opening its vast warehouse of customers’ genetic data to a major pharmaceutical company, this time Pfizer.

Pfizer said Monday that its researchers will quickly run queries across 23andMe’s database of 650,000 patients in hopes of identifying new associations between genes, diseases and traits. At first, the New York City pharmaceutical giant will focus on the genetics of lupus in 5,000 23andMe customers ...

Read more

To category page